StepStone (STEP): The 30% Earnings Beat That Still Missed Consensus — And What the Private Wealth Buy-In Changes

No stock means anything in isolation. StepStone Group (STEP) reported fiscal Q1 2027 results on August 6 that look great in one mirror and thin in another. Fee-related earnings surged 30% to $105.6 million. AUM reached $245.4 billion, up 23% year-over-year. By the non-GAAP measures that actually run the business, the operating engine is humming. But total revenue came in at $378.9 million against a consensus forecast of $433 million. That's a $54 million miss. Adjusted EPS of $0.48 also lagged the $0.75 consensus. The stock rallied 15% in five days anyway. The disconnect between the numbers and the price move is the story.

The fee engine is real. The GAAP picture is an accounting mirage.

StepStone's core business — collecting management and advisory fees on private markets portfolios for institutional and high-net-worth clients — grew faster than almost anyone expected. Fee-related revenue (the non-GAAP measure that strips out volatile performance fees) rose 27% to $270.9 million. Fee-related earnings, the measure of what that revenue turns into after cash-based costs, jumped 30% to $105.6 million. The FRE margin expanded to 39% from 38% a year ago. Management is guiding for annualized fee-related earnings "well over $400 million" and management/advisory fees exceeding $1 billion. That's not aspiration language — it's a run rate they're already touching.

The GAAP net loss of $115.8 million ($1.41 per share) is not an operating failure. It's driven by the accounting treatment of StepStone's planned buy-in of the Private Wealth profits interests. StepStone currently doesn't own the full economics of its high-growth private wealth platform; a profits interest agreement channels a chunk of that subsidiary's adjusted net income to outside holders. The company has a put/call agreement to buy those interests out, with the call period beginning in calendar Q3 2027. The fair-value swings on that agreement hit the income statement hard. The private wealth platform itself is growing — total assets hit $21.8 billion, with record quarterly subscriptions of $2.8 billion. The buy-in will capture the full economics of that growth at what management expects to be at a discount to the public multiple. That transaction is the single most material catalyst on the horizon.

The peer comparison changes how you read the valuation.

StepStone doesn't trade in a vacuum. Compared to The Carlyle Group (CG), the nearest structural peer in the private markets intermediary space, STEP looks cheaper on revenue but carries more balance sheet complexity.

STEP trades at 3.0x price-to-sales; CG trades at 4.9x. STEP's revenue growth year-over-year is 69.7% on TTM data; CG's is negative 41.9% on a TTM basis, reflecting one-time deal proceeds distorting the trailing window. STEP's price-to-book is 6.9x versus CG's 2.4x. The STEP share yields 3.27% on dividends, slightly above Carlyle's 2.86%, with a quarterly dividend raised 18% to $0.33 plus a $0.55 supplemental payment.

Neither company has a clean trailing PE — STEP's is negative on GAAP losses, CG's sits at 48x on a one-time-deal-inflated denominator. Both are fundamentally businesses where the fee income trajectory, not the current GAAP net income, sets the value. On that axis, STEP is growing its fee base faster but trading at a revenue multiple that acknowledges it's still scaling.

What the factor stack says

Valuation: C+. At 3.0x sales, STEP is cheaper than Carlyle on a revenue basis but rich on book value. The negative GAAP PE makes traditional earnings multiples useless — you have to price this on fee run rates and the private wealth buy-in optionality. The 6.1 billion market cap implies the market is not fully crediting the $1 billion-plus fee run rate or the private wealth economics capture. Whether that's a gap or a risk depends on whether you believe the buy-in actually closes and on what terms.

Growth: A-. Fee-related revenue up 27%, fee-related earnings up 30%, AUM up 23%, total capital responsibility up 26%. Fee-earning AUM (the subset that actually generates management fees) grew 21% to $153.6 billion. The blended management fee rate on fee-earning AUM has climbed to 65 basis points from 52 basis points in fiscal 2022 — that's rate expansion layered on top of volume growth. Focused commingled funds now represent 46% of fee-earning AUM, up from 34% in fiscal 2022, and generate 61% of fee revenues. This is the structural shift that makes the growth durable rather than cyclical: more capital in evergreen-style commingled structures, less dependence on one-off separately managed accounts.

Profitability: B. FRE margin at 39% is solid and expanding. But the company has negative operating margins on a GAAP basis (-51.3%) and negative ROIC (-42.4%), both distorted by the equity-based compensation charge ($317.3 million in the quarter) and the private wealth fair-value swings. On a cash basis, the underlying business is profitable and getting more so. The free cash flow margin of 3.2% on a TTM basis is thin but positive, up 6.7% year-over-year.

Safety: C+. Total debt of $5.9 billion against $1.1 billion in cash gives net debt of negative $881 million — the company is technically net cash. But the debt-to-equity ratio sits at 135.6% on $886 million in total equity, which looks stretched. Management targets its A+ investment-grade rating from Kroll as a bellwether for debt capacity and says it will use a mix of equity (up to 75%), cash, and potentially debt for the private wealth buy-in. The leverage profile is conservative in practice despite the headline ratio, because the debt is structured against fee income that's growing, not speculative.

Momentum: B-. The stock is up 15% over five days and 15% over 20 days, but down 21.6% year-to-date. The RSI is at 67.7, approaching overbought territory. The 50-day moving average sits at $44.30, the 200-day at $54.70 — the stock is between them, in that neutral zone where neither trend is dominant. AInvest's aggregate signal labels STEP a Buy, with a fundamental rating of 4.22. The momentum is positive but short-term, not structural yet.

The missing piece: why consensus was wrong

The $54 million revenue miss against consensus deserves a sentence of its own. Consensus was forecasting $433 million for the quarter; actual was $378.9 million. The miss came from performance fees, which are inherently lumpy. Total performance fees fell 28% year-over-year to $109.7 million. But the fee-related revenue — the recurring, predictable part — beat expectations. Analysts who price STEP on a blended revenue forecast including volatile carry will be disappointed in individual quarters. Investors who focus on the fee run rate won't be. The question is which lens the market is using when it sets the target.

Portfolio role and what to watch

STEP belongs in a growth sleeve, not a dividend or value bucket. It's a fee-scale story with optionality embedded in the private wealth buy-in. The stock is appropriate for an investor who believes private markets intermediation is a growing industry, that StepStone's shift to commingled funds creates structural durability, and that the buy-in transaction will close and be accretive. Every one of those assumptions is supported by the current trajectory but none is guaranteed.

What would change the view? A failure to close the private wealth buy-in on reasonable terms would remove the primary catalyst. A sustained decline in new inflows — the last 12 months saw nearly $40 billion in gross AUM additions, the best period in company history — would pressure the growth narrative. Rising interest rates that compress the demand for private debt and infrastructure would hit the fee base directly. Conversely, if the buy-in closes and SPRING (the private wealth flagship fund) continues to attract capital, the EPS accretion could be material enough to re-rate the stock above its current peer multiples.

At 3.0x sales with a 3.3% dividend and a $400 million-plus annual fee run rate, the current price reflects a company that's growing but not yet fully scaled. That's a specific place to be: not cheap enough to ignore valuation risk, not expensive enough to demand perfection from the next catalyst.